Found: 11
Select item for more details and to access through your institution.
A US payer perspective health economic model assessing value of monitoring disease activity to inform discontinuation and re-initiation of DMT in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 3, p. 432, doi. 10.1177/13524585241227372
- By:
- Publication type:
- Article
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis.
- Published in:
- Annals of Clinical & Translational Neurology, 2024, v. 11, n. 3, p. 729, doi. 10.1002/acn3.51996
- By:
- Publication type:
- Article
Serum Biomarker Signatures of Choroid Plexus Volume Changes in Multiple Sclerosis.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 7, p. 824, doi. 10.3390/biom14070824
- By:
- Publication type:
- Article
Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates.
- Published in:
- British Journal of Pharmacology, 2006, v. 148, n. 8, p. 1116, doi. 10.1038/sj.bjp.0706828
- By:
- Publication type:
- Article
Association between serum multi-protein biomarker profile and real-world disability in multiple sclerosis.
- Published in:
- Brain Communications, 2024, v. 6, n. 1, p. 1, doi. 10.1093/braincomms/fcad300
- By:
- Publication type:
- Article
Proteomics and relationship with axonal pathology in multiple sclerosis: 5-year diffusion tensor imaging study.
- Published in:
- Brain Communications, 2023, v. 5, n. 3, p. 1, doi. 10.1093/braincomms/fcad183
- By:
- Publication type:
- Article
Inflammatory and neurodegenerative serum protein biomarkers increase sensitivity to detect clinical and radiographic disease activity in multiple sclerosis.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48602-9
- By:
- Publication type:
- Article
Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0760-9
- By:
- Publication type:
- Article
Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 1, doi. 10.1186/s13075-015-0760-9
- By:
- Publication type:
- Article
Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
- Published in:
- Arthritis Research & Therapy, 2015, v. 17, n. 1, p. 239, doi. 10.1186/s13075-015-0760-9
- By:
- Publication type:
- Article
Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis.
- Published in:
- Proteomics - Clinical Applications, 2023, v. 17, n. 3, p. 1, doi. 10.1002/prca.202200018
- By:
- Publication type:
- Article